Uroosa Ibrahim

503 total citations
45 papers, 250 citations indexed

About

Uroosa Ibrahim is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Uroosa Ibrahim has authored 45 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Uroosa Ibrahim's work include Lymphoma Diagnosis and Treatment (8 papers), Immune Cell Function and Interaction (6 papers) and Lung Cancer Treatments and Mutations (5 papers). Uroosa Ibrahim is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Immune Cell Function and Interaction (6 papers) and Lung Cancer Treatments and Mutations (5 papers). Uroosa Ibrahim collaborates with scholars based in United States, India and Pakistan. Uroosa Ibrahim's co-authors include Jean Paul Atallah, Bachar Samra, Marcel Odaimi, Alla Keyzner, Nikhil Nalluri, Kartikeya Rajdev, Michel Chalhoub, Shafinaz Hussein, Deepak Asti and Farhan Mohammad and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Uroosa Ibrahim

42 papers receiving 247 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Uroosa Ibrahim United States 10 108 96 59 38 28 45 250
Hiroko Chikamoto Japan 12 74 0.7× 64 0.7× 68 1.2× 48 1.3× 41 1.5× 30 381
M. López-Andréu Spain 9 73 0.7× 66 0.7× 36 0.6× 75 2.0× 26 0.9× 12 315
Shohei Hamada Japan 11 142 1.3× 173 1.8× 36 0.6× 120 3.2× 22 0.8× 33 351
Aaron J. Feinstein United States 11 124 1.1× 95 1.0× 57 1.0× 152 4.0× 23 0.8× 18 339
Kemal Beksaç Türkiye 10 65 0.6× 52 0.5× 23 0.4× 86 2.3× 25 0.9× 37 279
Omar Abughanimeh United States 9 55 0.5× 78 0.8× 17 0.3× 56 1.5× 34 1.2× 54 215
Paul Legendre France 10 46 0.4× 100 1.0× 66 1.1× 29 0.8× 30 1.1× 29 314
L.T. Vlasveld Netherlands 11 150 1.4× 81 0.8× 34 0.6× 65 1.7× 22 0.8× 16 295
Bong-Seog Kim South Korea 10 121 1.1× 130 1.4× 22 0.4× 60 1.6× 59 2.1× 15 296
Masaru Togashi Japan 11 46 0.4× 105 1.1× 39 0.7× 23 0.6× 72 2.6× 30 296

Countries citing papers authored by Uroosa Ibrahim

Since Specialization
Citations

This map shows the geographic impact of Uroosa Ibrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uroosa Ibrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uroosa Ibrahim more than expected).

Fields of papers citing papers by Uroosa Ibrahim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uroosa Ibrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uroosa Ibrahim. The network helps show where Uroosa Ibrahim may publish in the future.

Co-authorship network of co-authors of Uroosa Ibrahim

This figure shows the co-authorship network connecting the top 25 collaborators of Uroosa Ibrahim. A scholar is included among the top collaborators of Uroosa Ibrahim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uroosa Ibrahim. Uroosa Ibrahim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCurdy, Shannon R., Scott R. Solomon, Brian C. Shaffer, et al.. (2025). Post-Transplant Cyclophosphamide Improves Survival in HLA-DPB1 Mismatched Unrelated Donor Allogeneic Transplantation. Transplantation and Cellular Therapy. 32(1). 74.e1–74.e14.
2.
Jacobs, Samantha E., Uroosa Ibrahim, Usha Govindarajulu, et al.. (2024). Dynamics of cytomegalovirus‐specific T‐cell recovery in allogeneic hematopoietic cell transplant recipients using a commercially available flow cytometry assay: A pilot study. Transplant Infectious Disease. 26(3). e14290–e14290. 2 indexed citations
3.
Ibrahim, Uroosa, Julio C. Chávez, Farhad Khimani, et al.. (2023). CAR T Cell Therapy for Post-Transplant Lymphoproliferative Disorder After Solid Organ Transplantation: A Safe and Feasible Therapy for an Orphan Disease. Clinical Lymphoma Myeloma & Leukemia. 23(10). 772–778. 1 indexed citations
4.
Ibrahim, Uroosa & Alla Keyzner. (2022). Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation. Hematology Transfusion and Cell Therapy. 45(4). 510–512. 5 indexed citations
5.
Ibrahim, Uroosa & Alla Keyzner. (2020). Autoimmune hematologic complications of umbilical cord blood transplantation. Hematology/Oncology and Stem Cell Therapy. 14(2). 104–109. 2 indexed citations
6.
Ibrahim, Uroosa, et al.. (2020). Gastric and small bowel perforations secondary to mucormycosis and graft versus host disease in an allogeneic transplant host. Hematology Transfusion and Cell Therapy. 43(4). 507–511. 1 indexed citations
7.
Rajdev, Kartikeya, et al.. (2018). An Unusually Aggressive Large Cell Carcinoma of the Lung: Undiagnosed until Autopsy. Cureus. 10(2). e2202–e2202. 10 indexed citations
8.
Ibrahim, Uroosa, et al.. (2018). An unusual complication of pigtail catheter insertion. Journal of Thoracic Disease. 10(10). 5964–5967. 3 indexed citations
9.
10.
Rajdev, Kartikeya, et al.. (2018). Sarcomatoid Carcinoma of the Lung Presenting as Localized Bronchiectasis: A Case Report and Review of Literature. Respiratory Medicine Case Reports. 24. 143–146. 6 indexed citations
11.
Ibrahim, Uroosa, et al.. (2017). Mortality among high-risk patients admitted with septic shock to U.S. teaching hospitals in July: Does the ‘July Effect’ exist?. Heart & Lung. 46(2). 110–113. 11 indexed citations
12.
Ibrahim, Uroosa, et al.. (2017). Embryonal Rhabdomyosarcoma of the Cervix: A Rare Disease at an Uncommon Age. Cureus. 9(11). e1864–e1864. 11 indexed citations
13.
Ibrahim, Uroosa, et al.. (2017). IgG4-related Disease Presenting as a Pancreatic Mass and Bilateral Lacrimal Gland Swelling . Cureus. 9(2). e1054–e1054. 1 indexed citations
14.
Ibrahim, Uroosa, et al.. (2017). EGFR exon 18 delE709_T710insD mutated stage IV lung adenocarcinoma with response to afatinib. Lung Cancer. 108. 45–47. 20 indexed citations
15.
Ibrahim, Uroosa, et al.. (2017). Adenocarcinoma Ex-goblet Cell Carcinoid of the Appendix: a Case Report and Overview of the Disease. Journal of Gastrointestinal Cancer. 49(4). 497–500. 3 indexed citations
16.
17.
Ibrahim, Uroosa, et al.. (2017). T Cell Histiocyte Rich Large B Cell Lymphoma Presenting as Hemophagocytic Lymphohistiocytosis: An Uncommon Presentation of a Rare Disease. Case Reports in Oncological Medicine. 2017(1). 6428461–6428461. 3 indexed citations
18.
Ibrahim, Uroosa, et al.. (2016). Persistence of a Cervical Neck Mass, Not Just the Lymphoma. Cureus. 8(8). e746–e746. 1 indexed citations
19.
Ibrahim, Uroosa, et al.. (2016). An Unusual Presentation of Nocardiosis in an Allogeneic Transplant Recipient. Cureus. 8(10). e834–e834. 4 indexed citations
20.
Ibrahim, Uroosa, et al.. (2016). Esophageal Granular Cell Tumor: A Case Report and Review of Literature. Cureus. 8(9). e782–e782. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroko Chikamoto Breakdown of academic impact, for papers by M. López-Andréu Breakdown of academic impact, for papers by Shohei Hamada Breakdown of academic impact, for papers by Aaron J. Feinstein Breakdown of academic impact, for papers by Kemal Beksaç Breakdown of academic impact, for papers by Omar Abughanimeh Breakdown of academic impact, for papers by Paul Legendre Breakdown of academic impact, for papers by L.T. Vlasveld Breakdown of academic impact, for papers by Bong-Seog Kim Breakdown of academic impact, for papers by Masaru Togashi
Rankless by CCL
2026